Ambuja Cements (AMBUJACEM) — Financial Results

Ambuja Cements reported unaudited financial results for the quarter and nine months ended December 31, 2024, showing revenue of ₹331.8 crores and profit after tax of ₹18.02 crores, reflecting 18.4% YoY revenue growth and 22.7% YoY profit growth. The filing, approved on January 29, 2025, and published in Financial Express, includes segment-wise performance, dividend declarations, and regulatory disclosures. Operational highlights include 87% capacity utilization and new plant commissioning in Eastern India. The results were disclosed during a board meeting and uploaded to the company website.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this financial results affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 30 January 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 30 January 2025

SRF SRF Limited Insider Trading SRF SRF Limited Financial Results SRF SRF Limited Financial Results SRF SRF Limited Financial Results TATACONSUM TATA CONSUMER PRODUCTS LIMITED Financial Results SRF SRF Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.